AzurRx BioPharma, Inc. carries a market capitalization of 3.43M, placing it among publicly traded companies globally.
| Market Cap | 3.43M |
| Enterprise Value | N/A |
AzurRx BioPharma, Inc.'s stock has gained approximately 141.25874% over the past 52 weeks. The 50-day moving average sits at 4.94, while the 200-day moving average is 7.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | 141.25874% |
| 50-Day Moving Average | 4.94 |
| 200-Day Moving Average | 7.50 |
| Average Volume (20 Days) | N/A |
AzurRx BioPharma, Inc.'s most recent stock split took place on September 13, 2021 with a 10:1 split ratio.
| Last Split Date | 9/13/2021 |
| Split Ratio | 10:1 |